$0.4134
0.0118[2.94%]
At close: Apr 22
$0.4134
0[0.00%]
After Hours: 6:15PM EDT
Cadrenal Therapeutics
(NASDAQ:CVKD)Cadrenal Therapeutics Stock (NASDAQ:CVKD), Quotes and News Summary
Cadrenal Therapeutics Stock (NASDAQ: CVKD) stock price, news, charts, stock research, profile.
| Open | $0.419 |
| Close | $0.407 |
| Volume / Avg. | 63.911K / 438.129K |
| Day Range | 0.396 - 0.440 |
| 52 Wk Range | 0.360 - 3.140 |
| Market Cap | $6.618M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 35 |
| Short Interest | 0.49% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cadrenal Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, teca...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cadrenal Therapeutics (CVKD) stock?
You can purchase shares of Cadrenal Therapeutics (NASDAQ: CVKD) through any online brokerage.
Who are Cadrenal Therapeutics's (CVKD) competitors?
Other companies in Cadrenal Therapeutics’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Palisade Bio (NASDAQ:PALI) and Hepion Pharmaceuticals (NASDAQ:HEPA).
What is the target price for Cadrenal Therapeutics (CVKD) stock?
The latest price target for Cadrenal Therapeutics (NASDAQ: CVKD) was reported by HC Wainwright & Co. on Thursday, March 14, 2024. The analyst firm set a price target for 3.00 expecting CVKD to rise to within 12 months (a possible 625.69% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Cadrenal Therapeutics (CVKD)?
The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $0.4134 last updated April 22, 2024 at 6:15 PM EDT.
Does Cadrenal Therapeutics (CVKD) pay a dividend?
There are no upcoming dividends for Cadrenal Therapeutics.
When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?
Cadrenal Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is Cadrenal Therapeutics (CVKD) going to split?
There is no upcoming split for Cadrenal Therapeutics.
What sector and industry does Cadrenal Therapeutics (CVKD) operate in?
Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.